Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q3 2014 Earnings

7AugConfirmed

Q4 2013

Q1 2014

Q2 2014

Q3 2014

-1.33

-1.17

-1.02

-0.86

Details

Expected EPS

-1.284696

Actual EPS

-1.3305779999999998

Surprise EPS

-0.05

Surprise Percent

+3.57%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -1.3305779999999998 per share for Q3 2014.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.